Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SIPA1L3 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | ASCL5 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | USP32 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | SLAMF8 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | CYP2C19 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | AC002398.9 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | N4BP2L2 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | DENND6A | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | AK7 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |